my account  log out
 

Anti-ERBB2 (Trastuzumab-LC-K149)-DBCO-MMAF ADC

Create: 09/27/2017
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant,LC-K149) conjugated via a DBCO linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. https://www.creative-biolabs.com/adc/target-erbb2-37.htm
City:[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer115
Feb 01 2023 GVBE Buffer112
Feb 01 2023 GVB++ (with Ca and Mg) Buffer121
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)111
Aug 30 2019Anti-HSV-2 gH Antibody292
Aug 30 2019Anti-L. major LPG Antibody304
Aug 30 2019Anti-DENV-1 Antibody278
Aug 30 2019Anti-BPV-1 L1 Antibody302
Aug 30 2019Anti-H3N2 HA Antibody287
Aug 30 2019Anti-EIAV env Antibody303

return back

Copyright © 2012-2017 toextrade Inc. All rights reserved. Contact us   DeepData©